(1.02%) 5 099.96 points
(0.40%) 38 240 points
(2.03%) 15 928 points
(0.11%) $83.66
(-1.16%) $1.619
(0.30%) $2 349.60
(-0.43%) $27.52
(0.42%) $924.40
(0.32%) $0.935
(0.67%) $11.02
(0.13%) $0.800
(-0.07%) $92.11
-9.25% $ 0.665
Live Chart Being Loaded With Signals
Citius Pharmaceuticals, Inc., a specialty pharmaceutical company, engages in the development and commercialization of critical care products focusing on anti-infective products in adjunct cancer care, prescription products, and mesenchymal stem cell therapy...
Stats | |
---|---|
Dzisiejszy wolumen | 2.77M |
Średni wolumen | 881 503 |
Kapitalizacja rynkowa | 105.77M |
EPS | $-0.0700 ( 2024-02-09 ) |
Następna data zysków | ( $-0.0600 ) 2024-05-10 |
Last Dividend | $0 ( N/A ) |
Next Dividend | $0 ( N/A ) |
P/E | -2.56 |
ATR14 | $0.00200 (0.30%) |
Date | Person | Action | Amount | type |
---|---|---|---|---|
2024-04-03 | Mazur Leonard L | Buy | 1 165 048 | Warrant to Purchase Common Stock |
2024-04-03 | Mazur Leonard L | Sell | 1 165 048 | Warrant to Purchase Common Stock |
2024-04-03 | Holubiak Myron Z | Buy | 129 450 | Warrant to Purchase Common Stock |
2024-04-03 | Holubiak Myron Z | Sell | 129 450 | Warrant to Purchase Common Stock |
2024-03-14 | Smith Robert Joseph | Buy | 75 000 | Stock Option (Right to Purchase Common Stock) |
INSIDER POWER |
---|
43.31 |
Last 96 transactions |
Buy: 27 334 255 | Sell: 1 367 765 |
Wolumen Korelacja
Citius Pharmaceuticals Korelacja
10 Najbardziej pozytywne korelacje | |
---|---|
FICS | 0.886 |
HEAR | 0.877 |
RNEM | 0.868 |
VIGI | 0.866 |
NTRSO | 0.865 |
RMRM | 0.861 |
PID | 0.86 |
TCON | 0.856 |
TZOO | 0.856 |
GAINL | 0.854 |
10 Najbardziej negatywne korelacje |
---|
Did You Know?
Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).
Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.
Citius Pharmaceuticals Korelacja - Waluta/Towar
Citius Pharmaceuticals Finanse
Annual | 2023 |
Przychody: | $0 |
Zysk brutto: | $-194 316 (0.00 %) |
EPS: | $-0.220 |
FY | 2023 |
Przychody: | $0 |
Zysk brutto: | $-194 316 (0.00 %) |
EPS: | $-0.220 |
FY | 2022 |
Przychody: | $0 |
Zysk brutto: | $-179 677 (0.00 %) |
EPS: | $-0.230 |
FY | 2021 |
Przychody: | $0.00 |
Zysk brutto: | $0.00 (0.00 %) |
EPS: | $-0.230 |
Financial Reports:
No articles found.
Citius Pharmaceuticals
Citius Pharmaceuticals, Inc., a specialty pharmaceutical company, engages in the development and commercialization of critical care products focusing on anti-infective products in adjunct cancer care, prescription products, and mesenchymal stem cell therapy. The company is developing five proprietary products comprising Mino-Lok, an antibiotic lock solution to treat patients with catheter-related bloodstream infections by salvaging the infected catheter; Mino-Wrap, a liquifying gel-based wrap for reduction of tissue expander infections following breast reconstructive surgeries; Halo-Lido, a corticosteroid-lidocaine topical formulation that intends to provide anti-inflammatory and anesthetic relief to persons suffering from hemorrhoids; NoveCite, a mesenchymal stem cell therapy for the treatment of acute respiratory disease syndrome; and I/ONTAK, an engineered IL-2 diphtheria toxin fusion protein for the treatment of patients with persistent or recurrent cutaneous T-cell lymphoma. Citius Pharmaceuticals, Inc. was founded in 2007 and is headquartered in Cranford, New Jersey.
O Sygnały na żywo
Prezentowane na tej stronie sygnały na żywo pomagają określić, kiedy KUPIĆ lub SPRZEDAĆ BRAK DANYCH. Sygnały mogą mieć opóźnienie wynoszące nawet 1 minutę; jak wszystkie sygnały rynkowe, istnieje ryzyko błędu lub pomyłki.
Sygnały transakcyjne na żywo nie są ostateczne i getagraph.com nie ponosi odpowiedzialności za żadne działania podjęte na podstawie tych sygnałów, jak opisano w Warunkach Użytkowania. Sygnały opierają się na szerokim zakresie wskaźników analizy technicznej